New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
07:45 EDTTEVATeva may face damages from early sale of generic Protonix, WSJ reports
Teva Pharmaceutical Industries (TEVA) may be responsible for up to $2.1B in damages because it sold generic copies of Pfizer's (PFE) heartburn reliever Protonix before the drug's U.S. patent exclusivity expired in 2011, reports the Wall Street Journal. Reference Link
News For TEVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 20, 2014
06:28 EDTTEVAAllergan price target raised to $210 from $190 at Citigroup
Subscribe for More Information
October 14, 2014
11:23 EDTTEVABIND Therapeutics and The Conference Forum hold a conference
Subscribe for More Information
11:19 EDTTEVATeva upgraded to Buy from Hold at Standpoint Research

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use